Cargando…
A pilot randomised controlled trial to assess the utility of an e‐learning package that trains users in adverse drug reaction causality
OBJECTIVES: Causality assessment of adverse drug reactions (ADRs) by healthcare professionals is often informal which can lead to inconsistencies in practice. The Liverpool Causality Assessment Tool (LCAT) offers a systematic approach. An interactive, web‐based, e‐learning package, the Liverpool ADR...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755231/ https://www.ncbi.nlm.nih.gov/pubmed/26032626 http://dx.doi.org/10.1111/ijpp.12197 |
_version_ | 1782416171521277952 |
---|---|
author | Conroy, Elizabeth J. Kirkham, Jamie J. Bellis, Jennifer R. Peak, Matthew Smyth, Rosalind L. Williamson, Paula R. Pirmohamed, Munir |
author_facet | Conroy, Elizabeth J. Kirkham, Jamie J. Bellis, Jennifer R. Peak, Matthew Smyth, Rosalind L. Williamson, Paula R. Pirmohamed, Munir |
author_sort | Conroy, Elizabeth J. |
collection | PubMed |
description | OBJECTIVES: Causality assessment of adverse drug reactions (ADRs) by healthcare professionals is often informal which can lead to inconsistencies in practice. The Liverpool Causality Assessment Tool (LCAT) offers a systematic approach. An interactive, web‐based, e‐learning package, the Liverpool ADR Causality Assessment e‐learning Package (LACAeP), was designed to improve causality assessment using the LCAT. This study aimed to (1) get feedback on usability and usefulness on the LACAeP, identify areas for improvement and development, and generate data on effect size to inform a larger scale study; and (2) test the usability and usefulness of the LCAT. METHODS: A pilot, single‐blind, parallel‐group, randomised controlled trial hosted by the University of Liverpool was undertaken. Participants were paediatric medical trainees at specialty training level 1+ within the Mersey and North‐West England Deaneries. Participants were randomised (1 : 1) access to the LACAeP or no training. The primary efficacy outcome was score by correct classification, predefined by a multidisciplinary panel of experts. Following participation, feedback on both the LCAT and the LACAeP was obtained, via a built in survey, from participants. KEY FINDINGS: Of 57 randomised, 35 completed the study. Feedback was mainly positive although areas for improvement were identified. Seventy‐four per cent of participants found the LCAT easy to use and 78% found the LACAeP training useful. Sixty‐one per cent would be unlikely to recommend the training. Scores ranged from 4 to 13 out of 20. The LACAeP increased scores by 1.3, but this was not significant. CONCLUSIONS: Improving the LACAeP before testing it in an appropriately powered trial, informed by the differences observed, is required. Rigorous evaluation will enable a quality resource that will be of value in healthcare professional training. |
format | Online Article Text |
id | pubmed-4755231 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-47552312016-02-25 A pilot randomised controlled trial to assess the utility of an e‐learning package that trains users in adverse drug reaction causality Conroy, Elizabeth J. Kirkham, Jamie J. Bellis, Jennifer R. Peak, Matthew Smyth, Rosalind L. Williamson, Paula R. Pirmohamed, Munir Int J Pharm Pract Research Papers OBJECTIVES: Causality assessment of adverse drug reactions (ADRs) by healthcare professionals is often informal which can lead to inconsistencies in practice. The Liverpool Causality Assessment Tool (LCAT) offers a systematic approach. An interactive, web‐based, e‐learning package, the Liverpool ADR Causality Assessment e‐learning Package (LACAeP), was designed to improve causality assessment using the LCAT. This study aimed to (1) get feedback on usability and usefulness on the LACAeP, identify areas for improvement and development, and generate data on effect size to inform a larger scale study; and (2) test the usability and usefulness of the LCAT. METHODS: A pilot, single‐blind, parallel‐group, randomised controlled trial hosted by the University of Liverpool was undertaken. Participants were paediatric medical trainees at specialty training level 1+ within the Mersey and North‐West England Deaneries. Participants were randomised (1 : 1) access to the LACAeP or no training. The primary efficacy outcome was score by correct classification, predefined by a multidisciplinary panel of experts. Following participation, feedback on both the LCAT and the LACAeP was obtained, via a built in survey, from participants. KEY FINDINGS: Of 57 randomised, 35 completed the study. Feedback was mainly positive although areas for improvement were identified. Seventy‐four per cent of participants found the LCAT easy to use and 78% found the LACAeP training useful. Sixty‐one per cent would be unlikely to recommend the training. Scores ranged from 4 to 13 out of 20. The LACAeP increased scores by 1.3, but this was not significant. CONCLUSIONS: Improving the LACAeP before testing it in an appropriately powered trial, informed by the differences observed, is required. Rigorous evaluation will enable a quality resource that will be of value in healthcare professional training. John Wiley and Sons Inc. 2015-05-29 2015-12 /pmc/articles/PMC4755231/ /pubmed/26032626 http://dx.doi.org/10.1111/ijpp.12197 Text en © 2015 The Authors. International Journal of Pharmacy Practice published by John Wiley & Sons Ltd on behalf of Royal Pharmaceutical Society. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Papers Conroy, Elizabeth J. Kirkham, Jamie J. Bellis, Jennifer R. Peak, Matthew Smyth, Rosalind L. Williamson, Paula R. Pirmohamed, Munir A pilot randomised controlled trial to assess the utility of an e‐learning package that trains users in adverse drug reaction causality |
title | A pilot randomised controlled trial to assess the utility of an e‐learning package that trains users in adverse drug reaction causality |
title_full | A pilot randomised controlled trial to assess the utility of an e‐learning package that trains users in adverse drug reaction causality |
title_fullStr | A pilot randomised controlled trial to assess the utility of an e‐learning package that trains users in adverse drug reaction causality |
title_full_unstemmed | A pilot randomised controlled trial to assess the utility of an e‐learning package that trains users in adverse drug reaction causality |
title_short | A pilot randomised controlled trial to assess the utility of an e‐learning package that trains users in adverse drug reaction causality |
title_sort | pilot randomised controlled trial to assess the utility of an e‐learning package that trains users in adverse drug reaction causality |
topic | Research Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755231/ https://www.ncbi.nlm.nih.gov/pubmed/26032626 http://dx.doi.org/10.1111/ijpp.12197 |
work_keys_str_mv | AT conroyelizabethj apilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality AT kirkhamjamiej apilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality AT bellisjenniferr apilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality AT peakmatthew apilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality AT smythrosalindl apilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality AT williamsonpaular apilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality AT pirmohamedmunir apilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality AT conroyelizabethj pilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality AT kirkhamjamiej pilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality AT bellisjenniferr pilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality AT peakmatthew pilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality AT smythrosalindl pilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality AT williamsonpaular pilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality AT pirmohamedmunir pilotrandomisedcontrolledtrialtoassesstheutilityofanelearningpackagethattrainsusersinadversedrugreactioncausality |